Pharmaceutical

Can Community Outreach Stop the Growing Measles Crisis?
Clinical & Pharma Can Community Outreach Stop the Growing Measles Crisis?

The resurgence of measles in urban centers like London has reached a critical juncture that demands a fundamental shift in how public health departments engage with local communities. Recent data from the early months of 2026 indicates a sharp rise in infections, with Enfield reporting dozens of

CVS Health Enhances Patient Engagement With AI Agentic Twins
Tech & Innovation CVS Health Enhances Patient Engagement With AI Agentic Twins

James Maitland is a leading expert in robotics and IoT applications within the medical field, dedicated to pioneering digital solutions that enhance patient care. His work focuses on the intersection of human behavior and technology, specifically how advanced modeling can predict and improve

How Can Specialty Pharmacies Help Patients Manage Chronic Illness?
Tech & Innovation How Can Specialty Pharmacies Help Patients Manage Chronic Illness?

James Maitland is a leading expert in the integration of robotics and IoT within the medical field, dedicated to transforming healthcare delivery through high-tech, patient-centered solutions. In this discussion, we explore the intricate landscape of specialty pharmacy services, focusing on how

Moderna Settles mRNA Patent Lawsuit for $2.25 Billion
Clinical & Pharma Moderna Settles mRNA Patent Lawsuit for $2.25 Billion

The global pharmaceutical landscape has undergone a seismic shift following the formal announcement that Moderna has agreed to a massive two-point-two-five billion dollar settlement with Genevant Sciences and Arbutus Biopharmaceutical to resolve long-standing disputes over lipid nanoparticle

Can AI Speed Up Rare Disease Clinical Trial Enrollment?
Clinical & Pharma Can AI Speed Up Rare Disease Clinical Trial Enrollment?

The traditional bottleneck of clinical trials for rare diseases often leaves patients waiting years for life-saving treatments while researchers manually sift through mountains of digital paperwork. In a significant move to address this, the Cleveland Clinic and Dyania Health recently published a

Seaport Receives $15 Million to Develop Lymphatic Therapies
Clinical & Pharma Seaport Receives $15 Million to Develop Lymphatic Therapies

The traditional understanding of the human lymphatic system as a mere drainage network is undergoing a radical transformation as modern medicine uncovers its profound role in chronic disease and immune regulation. This shift in perspective is at the forefront of a new collaboration between Seaport

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later